Andy Studna

A passion for building the business engine behind treatments for rare disease.

Innovation Without Bounds

Hopeful new standard of care for advanced prostate cancer capitalizing on momentum.

Standard for reaching patients shifts with influx of new technology in post-COVID world.

Fast riser in biotech strategy execution seizes on opportunities in immunotherapy.

An evolving job market has forced life sciences companies to respond.

How the pivot to corporate development became a natural fit for the once-destined scientist. (The story of Natasha A. Hernday, chief business officer of Seagen and a 2023 Emerging Pharma Leader.)

Despite significant advances in the scientific understanding of human immunodeficiency virus (HIV) in recent years, there is still an unmet need for those living with the virus. Particularly those individuals who have already tried several therapies and are unable to maintain virologic suppression due to resistance, intolerance, and/or safety considerations. This is an area Gilead Sciences has identified and is looking to address with its new HIV-1 therapy, Sunlenca (lenacapavir). After rec…

The world of biopharma is rife with challenges beyond the cost of research and development, including increased competition, patent expirations, and new regulatory guidance. As such, companies are under pressure to launch their products as quickly and efficiently as possible. An in-depth study conducted by Indegene and Everest Group delved into these challenges by identifying and addressing the key reasons that new products miss their launch forecasts.1 “In this uncertain and risky environm…

Following a review spanning November and December 2023, on December 29, 2023, the US District Court for the Southern District of New York granted the Federal Trade Commission’s (FTC) request for a preliminary block to prevent IQVIA from acquiring Propel Media.1 The FTC originally sued to block the acquisition in July 2023. According to a press release from the FTC, “…the proposed acquisition would give IQVIA a market-leading position in programmatic advertising for health care products, namel…